Multicenter Observational study to evaluate the effectiveness of a biosimilar Etanercept (ErelziTM) in patients with established Rheumatic disease previously treated with reference etanercept. (BRONZE)

03/04/2019
20/01/2025
EU PAS number:
EUPAS28777
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information